Literature DB >> 2033403

A histometrical and comparative study on Purkinje cell loss and olivary nucleus cell loss in multiple system atrophy.

A Kume1, A Takahashi, Y Hashizume, J Asai.   

Abstract

We examined pathologically 21 cases of multiple system atrophy (MSA). Density of Purkinje cell in 16 cases and of olivary nucleus cell in 20 cases was quantitatively measured, and their distribution as well as degree were studied. Contrary to the findings of previous reports, Purkinje cell loss was more pronounced in the vermis than in the hemispheres. Olivary nucleus cell loss was more outstanding in the accessory nucleus than in the inferior nucleus. A topographical characteristic of cell degeneration exists between the Purkinje layer and the olivary nucleus. Significant sparing of the nodulus apparently related to that of the vestibular system was found. While the common distribution of cell loss was seen, its degree varied considerably case by case. The degree was related to both duration of illness and, to some extent, clinical subtypes of MSA.

Entities:  

Mesh:

Year:  1991        PMID: 2033403     DOI: 10.1016/0022-510x(91)90043-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

1.  Reduced Purkinje cell number in essential tremor: a postmortem study.

Authors:  Jordan E Axelrad; Elan D Louis; Lawrence S Honig; Ingrid Flores; G Webster Ross; Rajesh Pahwa; Kelly E Lyons; Phyllis L Faust; Jean Paul G Vonsattel
Journal:  Arch Neurol       Date:  2008-01

2.  Purkinje cell axonal anatomy: quantifying morphometric changes in essential tremor versus control brains.

Authors:  Rachel Babij; Michelle Lee; Etty Cortés; Jean-Paul G Vonsattel; Phyllis L Faust; Elan D Louis
Journal:  Brain       Date:  2013-09-12       Impact factor: 13.501

Review 3.  'Essential tremor' or 'the essential tremors': is this one disease or a family of diseases?

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2013-12-03       Impact factor: 3.282

4.  Spatiotemporal analysis of purkinje cell degeneration relative to parasagittal expression domains in a model of neonatal viral infection.

Authors:  Brent L Williams; Kavitha Yaddanapudi; Mady Hornig; W Ian Lipkin
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

5.  Infantile multiple system atrophy with cytoplasmic and intranuclear glioneuronal inclusions.

Authors:  M Bergmann; K Kuchelmeister; B Kryne-Kubat; F Burwinkel; K Harms; F Gullotta
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1.

Authors:  Ravi Chopra; David D Bushart; John P Cooper; Dhananjay Yellajoshyula; Logan M Morrison; Haoran Huang; Hillary P Handler; Luke J Man; Warunee Dansithong; Daniel R Scoles; Stefan M Pulst; Harry T Orr; Vikram G Shakkottai
Journal:  Hum Mol Genet       Date:  2020-11-25       Impact factor: 6.150

7.  Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging.

Authors:  M Ghaemi; R Hilker; J Rudolf; J Sobesky; W-D Heiss
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

8.  Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy.

Authors:  M Konagaya; Y Konagaya; M Iida
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

9.  Opsoclonus-myoclonus syndrome associated with multiple system atrophy.

Authors:  Kazumasa Shindo; Akiko Onohara; Takanori Hata; Fumikazu Kobayashi; Kaori Nagasaka; Takamura Nagasaka; Yoshihisa Takiyama
Journal:  Cerebellum Ataxias       Date:  2014-11-01

10.  Regional alterations in purkinje cell density in patients with autism.

Authors:  Jerry Skefos; Christopher Cummings; Katelyn Enzer; Jarrod Holiday; Katrina Weed; Ezra Levy; Tarik Yuce; Thomas Kemper; Margaret Bauman
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.